- About Us
- PCRS-UK Community
- PCRS-UK Committees and Trustees
- PCRS-UK Trustees
- PCRS-UK Executive
- PCRS-UK Education Committee
- PCRS-UK Conference Organising Committee
- PCRS-UK Service Development Committee
- Primary Care Respiratory Update Editorial Board
- Respiratory Leaders Programme Board
- PCRS-UK Affiliated Group Leaders Committee
- Policy Forum
- Lay Reference Group
- Interested in joining a committee?
- PCRS-UK Regional Leads
- Clinical Leadership Programme
- Local Groups
- Your questions answered
- Respiratory Researchers
- PCRS-UK Committees and Trustees
- Annual Conference
- Respiratory Clinical Leadership Programme
- Local Group Leaders Events
- Other Meetings
- Researchers Meeting
- Contact Us
Confirmed Conference Exhibitors
AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit www.astrazeneca.com
Boehringer Ingelheim For more than 130 years, our research-driven pharmaceutical company has created innovative medicines for people and animals. Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies and to this day remains family-owned. Every day, our 50,000 employees create value through innovation in our three business areas: human pharmaceuticals, animal health and biopharmaceutical contract manufacturing Social responsibility comes naturally to Boehringer Ingelheim. That’s why we are involved in social projects such as the “Making More Health” initiative. Boehringer Ingelheim also actively promotes workforce diversity and benefits from our employees’ different experiences and skills. Environmental protection and sustainability is the focus of everything we do. More information about Boehringer Ingelheim can be found on www.boehringer-ingelheim.com or in our annual report: http://annualreport.boehringer-ingelheim.com.
One in five of us has problems with our breathing. Millions more are at risk. We’re the only UK charity looking after the nation’s lungs. With your support, we’ll make sure that one day everyone breathes clean air with healthy lungs. For further information, please visit www.blf.org.uk. For help and support, call the BLF Helpline on 03000 030 555. To donate £5 to help the BLF fight lung disease, please text LUNGS to 70500.
Chiesi Limited is the UK affiliate of Chiesi Farmaceutici S.p.A. It is headquartered in Manchester and employs over 250 employees. Chiesi Farmaceutici is an international research-focussed Healthcare Group based in Parma, Italy, with over 80 years of experience in the pharmaceutical industry. The group employs nearly 5,000 people and has affiliates in 26 countries, with its products reaching over 70 countries. Chiesi researches, develops and markets innovative drugs in the respiratory therapeutics, specialist medicine and rare disease areas. Its R&D organisation is also headquartered in Parma, Italy, and integrated with six other key R&D groups in France, the USA, the UK, Sweden and Denmark to advance Chiesi's pre-clinical, clinical and registration programmes. R&D remains a key priority for Chiesi, with the product pipeline increasingly leveraging novel, proprietary therapeutics that target diseases with high unmet medical need, with the ultimate aim of giving patients access to innovative medicines that improve quality of life.
Cipla is a leading global pharmaceutical company, dedicated to high-quality, branded and generic medicines. We are trusted by healthcare professionals and patients across geographies. Over the last 8 decades, we have strengthened our leadership in India’s pharmaceutical industry and fortified our promise of ‘Caring for Life’. We are now strengthening our global focus by consolidating and deepening our presence in the key markets of India, South Africa, the UK, the US, and other economies of the emerging world
Respiratory specialists Clement Clarke International, have a series of innovative devices to showcase at the PCRS meeting. Visit us to see how we can enhance our Flo-Tone inhaler guidance mouthpiece using mobile Apps to make ensure correct use of inhaler devices. See also the latest on our Able, A2A and DispozABLE Spacers and our In-Check DIAL G16.
Improving the lives of people living with long term conditions - Education for Health is a leading UK based educational charity, supporting nurses and healthcare professionals working with patients living with long term conditions. Through our clinically led education and training, research and advocacy work, we are playing an integral role in enabling healthcare professionals to deliver the best possible care for patients. We offer a comprehensive range of education and training, including free-to-access online resources, workshops and accredited Level 5, 6 and 7 modules which can be taken as standalone courses or used to achieve a full DipHE, BSc or MSc degree programme. Our academic team are clinicians and experts in their subject areas who continue to work in practice, bringing a real-life vibrancy to all that we do. Innovative teaching techniques and learning materials enable students to combine work and professional development. Website: www.educationforhealth.org Email: email@example.com Twitter: @EdforHealth Facebook: www.facebook.com/EdforHealth/
GSK is a science-led global healthcare company with a mission to help people do more, feel better and live longer. For more than 45 years, GSK has been a leader in respiratory, helping patients with respiratory disease better manage their condition. Working in collaboration with the scientific community, we remain at the cutting-edge of scientific research into innovative medicines with the aim of helping to treat patients’ symptoms and reduce the risk of their disease. For further information please visit www.gsk.com.
The ILD Interdisciplinary Network (ILD-INN) aims to provide a supportive network for health professionals of all disciplines working in interstitial lung diseases. ILD-INNs purpose is, to provide support, promote ILD specialty practice through education and professional development and to influence the policy of ILD care.
MDUK is focused on high quality products that improve respiratory care. These include space chambers for the delivery of asthma and COPD medication, portable low-power consumption nebulisers and finger type pulse oximeters measuring SpO2. We have resently launched the Anti-Satic Space Chamber Plus Compact and Standard size Spacers for use with PMDIs. They are on perscription throughout the UK. The company’s products are available from most high street pharmacy chains.
Napp Pharmaceuticals Limited is a UK healthcare company with a strong track record in bringing high-quality, innovative medicines to UK health professionals and their patients. We are a committed long-term NHS provider in respiratory medicine, supporting the delivery of real-world evidence and education. We aim to provide high-quality asthma medicines that meet genuine needs, make a positive difference to patients’ lives and offer value to the NHS.
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. Novartis is the only global company with leading positions in these areas. Novartis Group companies employ approximately 119,000 full-time-equivalent associates. Novartis products are available in more than 180 countries around the world. For more information, please visit http://www.novartis.co.uk
PARI develop solutions for people suffering from respiratory diseases in the form of high-quality, reliable devices and has been a leading manufacturer within the respiratory field for well over 100 years. PARI has recently introduced a new range of diagnostic devices – consisting of the PARI SpiroSense® spirometry solution and the Bosch Vivatmo FeNO testing solution. The SpiroSense solution comprises an easy-to-use PC spirometer for healthcare professionals, with the option of adding a mobile handheld device for patients to use at home. SpiroSense automatically self-calibrates, removing the need for time-consuming calibration and servicing. The Vivatmo FeNO testing solution offers a simple, maintenance-free option that can be added to the patient pathway. Intuitive user guidance and visual animation enables easy measurements. This year PARI is also celebrating 50 Years of the PARI BOY nebuliser brand with a charity campaign – it is completely free to enter and all money raised will be donated to the British Lung Foundation. For further information visit the PARI stand. PARI Medical Ltd The Old Sorting Office Rosemount Avenue West Byfleet Surrey KT14 6LB Tel: 01932 341122 Fax: 01932 341134 www.pari.com email: firstname.lastname@example.org
At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines. Our diversified global healthcare portfolio includes biologic and small molecule medicines and vaccines, as well as many of the world’s best-known consumer products. Every day, Pfizer colleagues work to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. Please visit the Pfizer stand to hear more about smoking cessation and the Pfizer alliances with Novartis and Bristol-Myers Squibb and how we collaborate to improve the wellbeing of patients living with COPD and cardiovascular disease in the United Kingdom.
Philips, a global leader in the sleep and respiratory markets, is passionate about improving the quality of people’s lives with solutions that are designed around the needs of our customers and their patients. For Philips, innovation is driven by gaining insight into the needs of the people who use our products in the areas of sleep management, oxygen therapy, noninvasive ventilation and respiratory drug delivery. This tradition of innovation combined with our ability to anticipate market needs has made Philips a name acknowledged worldwide as a pace-setter in the markets we serve.
Queen Mary is a global leading university enhancing the regional, national and international agenda. We have a unique student, research and public engagement profile compared to any other university, pushing the boundaries of research and innovation and providing opportunities to individuals with talent and potential, irrespective of their background.
Respiratory Matters Ltd was founded in 2011 and offers training and education, mentorship, and project management, to support individuals, clinical commissioning groups and private companies to improve the care and outcomes of people with respiratory disease. We achieved the Clinical Skills & simulation Quality Assurance standards certificate from NHS Health Education Yorkshire and Humber in 2016. Education We deliver accredited foundation, interpretation and full spirometry certificate courses, Asthma and COPD diplomas and certificate courses, and bespoke respiratory education. We will deliver education anywhere in the country. We also lecture at Keele and Huddersfield Universities. Projects We are regularly commissioned by CCG’s for project management and education. • 2011. Yorkshire and Humber SHA and Asthma UK. First Paediatric Asthma Local Enhanced Service in the UK. Clinical Lead • 2012-2014. Calderdale CCG Living Well with asthma project (Paediatrics). Clinical Lead • 2015. Calderdale. Provision of COPD and spirometry education and project support for COPD case finding project. Education Lead • 2015 –2016 Leeds West CCG. Paediatric Asthma Project. Clinical Lead • 2017-2018. North Lancs, Blackburn and Darwen CCG. Delivery of accredited spirometry courses • 2018. Sheffield CCG. Delivery of accredited spirometry, asthma and COPD courses • 2018 Salford CCG, digital health innovation. Paediatric asthma. Project lead
Slater and Gordon is one of the UK’s leading consumer law firms. Our goal is to deliver exceptional, world class legal services in all aspects of injury and negligence, with offices throughout the UK. Slater and Gordon has a team of experts who specialise in asbestos related disease and can provide your patients with all the necessary advice to pursue a claim for compensation.
Trudell Medical UK Limited (TM-UK) TM-UK is committed to enhancing the quality of life for people of all ages with respiratory conditions. We are part of Trudell Medical International, a family owned healthcare company that designs, develops and manufactures a wide range of high quality, innovative medical devices and is home to a global Aerosol Lab and Research Centre. New AeroChamber Plus* Flow-Vu* Anti-Static Valved Holding Chamber (VHC) and our award-winning Aerobika* OPEP device, are now available on prescription in the UK. Come and see us to find out more.